The role of the ERK signaling pathway in promoting angiogenesis for treating ischemic diseases

Abstract

The main treatment strategy for ischemic diseases caused by conditions such as poor blood vessel formation or abnormal blood vessels involves repairing vascular damage and encouraging angiogenesis. One of the mitogen-activated protein kinase (MAPK) signaling pathways, the extracellular signal-regulated kinase (ERK) pathway, is followed by a tertiary enzymatic cascade of MAPKs that promotes angiogenesis, cell growth, and proliferation through a phosphorylation response. The mechanism by which ERK alleviates the ischemic state is not fully understood. Significant evidence suggests that the ERK signaling pathway plays a critical role in the occurrence and development of ischemic diseases. This review briefly describes the mechanisms underlying ERK-mediated angiogenesis in the treatment of ischemic diseases. Studies have shown that many drugs treat ischemic diseases by regulating the ERK signaling pathway to promote angiogenesis. The prospect of regulating the ERK signaling pathway in ischemic disorders is promising, and the development of drugs that specifically act on the ERK pathway may be a key target for promoting angiogenesis in the treatment of ischemic diseases.

Hemodynamic force dictates endothelial angiogenesis through MIEN1‐ERK/MAPK‐signaling axis

“…Additionally, previous studies have highlighted the critical role of p-ERK in regulating endothelial migration and proliferation, which is essential for angiogenesis. Song et al (2023). In our current study, we employed SCH772984 to demonstrate that shear stress-mediated ERK/MAPK signaling participates in angiogenesis.…”

Ononin: A comprehensive review of anticancer potential of natural isoflavone glycoside

“…Activation of ERK can increase the production of VEGF and enhance its binding to its receptor, VEGFR, thus amplifying the angiogenic signals. [46] In their study, Gong et al, [10] also found that ononin could suppress HIF-1α expression after 48 h of incubation. [10] Also, evidence from traditional Chinese medicines hints towards the potential inhibitory effect of ononin on HIF-1α.…”

Decoding Tumor Angiogenesis for Therapeutic Advancements: Mechanistic Insights

“…This activation leads to ECM breakdown, facilitating angiogenesis [53]. Additionally, VEGF induces a survival mechanism in ECs and promotes their migration and proliferation through MAPK/ERK and PI3K/Akt pathways [3,54]. PlGF, a member of the VEGF family, has a controversial role in tumor angiogenesis, with reports suggesting both proangiogenic and antiangiogenic properties.…”